See also this year's filing and all EDGAR filings for this company.
PDF Report 0001349929_2022_Vyant_Bio_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.12307589791430666, 'aggregate_val': 16854000, 'exp_sum': 15007000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 0, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 0, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 8424000, 'ResearchAndDevelopmentExpense': 4273000, 'remainder_Expenses': 2310000}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.27703715087018327, 'aggregate_val': 37636000, 'exp_sum': 52058000, 'exp_to_value': {'IntangibleAssets': 0, 'AssetsNonCurrent': 14422000, 'AssetsCurrent': 23214000, 'PropertyPlantAndEquipment': 1020000, 'remainder_Assets': 13402000}} |
Graph
Absolute values for 0001349929, Vyant Bio Inc.
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 14,422,000 |
| 2 | AssetsCurrent | 23,214,000 |
| 3 | PropertyPlantAndEquipment | 1,020,000 |
| 4 | remainder_Assets | -1,020,000 |
| 5 | LongTermLiabilities | 516,000 |
| 6 | LiabilitiesCurrent | 5,431,000 |
| 7 | remainder_Liabilities | 399,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 0 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 8,424,000 |
| 15 | ResearchAndDevelopmentExpense | 4,273,000 |
| 16 | remainder_Expenses | 4,157,000 |
| 17 | remainder_Revenues | 1,148,000 |
| 18 | remainder_NetIncome | -25,153,000 |
| 19 | remainder_ComprehensiveNetIncome | -74,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 37,636,000 |
| 1 | Liabilities | 6,346,000 |
| 2 | Expenses | 16,854,000 |
| 3 | Revenues | 1,148,000 |
| 4 | StockholdersEquity | 31,290,000 |
| 5 | NetIncome | -40,859,000 |
| 6 | ComprehensiveNetIncome | -40,933,000 |
| 7 | BaseVar | 50,738,285 |
| 8 | EconomicCapitalRatio | -0.0710 |
Edgar->Model Mapping
Feature Distribution
Change over Time
